American Healthcare REIT (AHR) came out with quarterly funds from operations (FFO) of $0.42 per share, beating the Zacks Consensus Estimate of $0.4 per share. This compares to FFO of $0.33 per share a year ago.
Get a deeper insight into the potential performance of American Healthcare REIT (AHR) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Are we in an AI bubble? And will it be AI or tariffs that determine the trajectory of the market going forward? I'm focusing on dividend growth stocks and ETFs with attractive yields and solid projected dividend growth rates. I estimate most of the stocks on my buy list will deliver mid- to high-single-digit dividend growth going forward.
American Healthcare REIT (AHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here is how American Healthcare REIT (AHR) and Apollo Commerical Finance (ARI) have performed compared to their sector so far this year.
Healthcare REITs have outperformed major indices, but several are now trading at significant premiums to fair value, warranting caution. This article takes a quick look at 5 such companies, with a thumbnail sketch and 9 key metrics. Despite strong growth prospects for some, high price/FFO ratios, elevated premiums to NAV, and dividend safety concerns make these REITs questionable at current prices.
REITs are positioned for accelerating earnings growth in 2026-2027, with management teams expressing increased optimism despite ongoing macro uncertainties. Key investment themes include AI-driven data centers, senior housing benefiting from demographic trends, and residential REITs capitalizing on the housing shortage. REITs offer resilient cash flows, potential dividend growth, and superior capital access, making them attractive relative to other asset classes in the current environment.
REITweek, the annual REIT industry conference, was held last week in New York City. Humbled by frustratingly persistent interest rate headwinds and historic underperformance, the venue halls were again quiet.
Despite positive market sentiment, economic headwinds are growing, with cracks forming in the housing and labor markets, signaling the potential for a mild downturn. REITs are attractively valued now due to their rate sensitivity, discounted valuations, and solid free cash flow growth prospects amid likely falling interest rates. I am buying five high-quality, low-leverage REITs, each offering strong dividend growth and sector leadership.
CRDO, FERG, AHR, BKNIY and FER have been added to the Zacks Rank #1 (Strong Buy) List on June 6, 2025.
American Healthcare REIT, Inc. (NYSE:AHR ) Q1 2025 Earnings Conference Call May 9, 2025 1:00 PM ET Company Participants Alan Peterson - Vice President, Investor Relations & Finance Danny Prosky - President & Chief Executive Officer Gabe Willhite - Chief Operating Officer Stefan Oh - Chief Investment Officer Brian Peay - Chief Financial Officer Conference Call Participants Farrell Granath - Bank of America Austin Wurschmidt - KeyBanc Capital Markets Michael Carroll - RBC Capital Markets Ronald Kamdem - Morgan Stanley Joe Dickstein - Jeffries Michael Stroyeck - Green Street Seth Bergey - Citi Operator Thank you for standing by. My name is Kate, and I will be your conference operator today.
The headline numbers for American Healthcare REIT (AHR) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.